Europe eyes arthritis drug for COVID-19 cases
AMSTERDAM – The European Medicines Agency has started an accelerated review process to determine if a common pain-management drug might help people hospitalized with severe infectious-disease, months after the drug was granted an emergency use authorization in the U.S. In a statement Monday, the EU drug regulator said it was assessing an application to extend…